Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users & Region (North America, Europe, APAC, Latin America & MEA) - Global Forecasts to 2026
Updated on : March 15, 2023
The global defibrillator market worth $18.2 billion by 2026, growing at a CAGR of 9.7% in the upcoming years.
Market growth is mainly driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs & CRT-Ds are expected to offer growth opportunities for players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and a lack of awareness about sudden cardiac arrest in developing nations are expected to hinder the growth of the market during the forecast period. Other factors such as limited reimbursements in developed nations, lack of infrastructure, particularly in developing and underdeveloped countries are also expected to hinder the growth of this market.
To know about the assumptions considered for the study, Request for Free Sample Report
Defibrillator Market Dynamics
Drivers: Rising prevalence of target disease
Cardiovascular disease (CVD) is a leading cause of death and disability across the globe. Globally, 17.9 million deaths due to CVD were reported in 2019, which amounts to 32% of the total deaths worldwide (Source: WHO). More than 75% of deaths due to CVDs occur in low- and middle-income countries. In the US alone, there were more than 390,000 sudden cardiac arrests in 2018 (Source: American Heart Association). Of the total US population, around 65% of deaths due to CVDs occur in people aged 75 and over, 29% in the age group of 55–74, and 6% in the age group of 35–54. Owing to this, the demand for defibrillators has increased, as these devices help save the lives of patients at a high risk of cardiac arrest.
The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also on the rise. There is a strong linear relationship between high blood pressure levels and the risk of developing CVDs. In the US, around 70% of people who have suffered from their first cardiovascular stroke, their first heart attack, and who have congestive heart failure, are reported to have a blood pressure of more than 140/90 mm Hg (Source: American Heart Association).
In Asian countries, over the last decade, the prevalence of CVD has increased due to the rising adoption of sedentary lifestyles, changing diets, increasing stress, and rising consumption of alcohol and tobacco. A study on heart disease conditions in Asia stated that the prevalence of heart diseases is expected to increase by over 110% between 2000 and 2020. Furthermore, CVD death rates in India are estimated to have risen from 155.7 to 209.1 per 100,000 between 1990 and 2016 (Source: Journal of the American College of Cardiology).
The rising geriatric population across the globe is another key factor contributing to the increasing prevalence of CVD, as aging is associated with progressive deterioration in the structure and function of the heart and acts as a catalyst in the development of chronic diseases. Thus, with the growth in the geriatric population across the globe, the incidence of heart diseases is expected to increase.
Opportunities: Emerging Markets
Emerging markets offer significant growth opportunities for players in the defibrillators market, owing to the rising incidence of cardiovascular disease and improving healthcare infrastructure in these countries. According to a research study published by the American Heart Association, annual cardiovascular events in China are projected to increase by more than 50% from 2010 to 2030. Similarly, cardiac ailments killed approximately 28% of Indians in 2016, double the numbers reported in 1990 when heart diseases caused 15% of the total number of deaths.
To leverage the high growth opportunities for defibrillator devices in emerging markets, manufacturers are strategically focusing on expanding their presence in these countries. For instance, in May 2016, Medtronic opened its Asia Pacific headquarters in Singapore to support operations at 80 locations in this region. In January 2016, Nihon Kohden Corporation established its sales subsidiary, Nihon Kohden Mexico S.A. de C.V., in Mexico to provide sales and aftersales support for the company’s products and services.
Regulatory policies in the Asia Pacific region are more adaptive and business-friendly due to fewer data requirements than in developed economies. Increasing competition in mature markets will further compel defibrillator manufacturers to focus on emerging markets in the coming years.
Restraints: Issues related to the use of implantable and automated external defibrillators
AEDs installed in public places are sometimes prone to failure due to problems pertaining to the battery, software, and hardware. Failure to perform defibrillation can result in delayed treatment or even death. Over the years, a number of defibrillators have been recalled due to technical errors in the functioning of the device with respect to shock delivery, electrical issues, and hardware configuration. These defects may lead to undesirable product performance and even the death of the patient in some cases. In 2018, the FDA, in conjunction with Philips, issued a recall notice for various models of the HeartStart MRx Defibrillator. The recall was caused by a defect in the gas discharge tube (GDT), which could lead to the malfunction of the defibrillator. In 2021, Medtronic recalled the Evera, Viva, Brava, Claria, Amplia, Compia, and Visa ICDs and CRT-Ds due to the short battery life associated with these devices.
Cybersecurity is another major concern in the defibrillator market. The new generation of implantable defibrillators is technologically advanced, allowing for remote data transfer. The FDA has raised concerns regarding the hacking of these devices. Medtronic was the latest company to face an FDA cybersecurity issue in 2019, as Medtronic’s wireless telemetry technology did not have encryption or authentication safety.
ICD leads also have a high rate of electrical failure. Around 4.5% of the 4,000-plus active Riata ICD leads had an electrical failure five years after implantation in Canada. Electrical failures are mainly caused due to the breakdown of insulation around the wires. Lead failures are associated with loss of device function, inappropriate shocks, and sometimes death. In 2020, Boston Scientific recalled its EMBLEM S-ICD due to a short circuit in the device.
Other major issues related to AEDs include faults in the defibrillation pads, wiring and circuit boards, and damaged cables and connectors. In some cases, the batteries of AEDs are removed when they are discharged; however, these batteries are not replaced on time. Although a number of initiatives are taken by public and private organizations as well as key market players to provide emergency services, these devices require proper maintenance and periodic servicing.
Challenges: Frequent product recalls
In recent years, the market has witnessed a number of product recalls mainly due to reasons related to electrical failure, connector compatibility issues, and issues pertaining to specific defibrillators. Between January 2005 and September 2014, the FDA received 72,000 medical device reports related to AED failure. In the same period, manufacturers of AEDs conducted 111 product recalls, affecting over 2 million AED units. During 2016–2019, the FDA issued around 70 product recalls for defibrillators/monitors, AEDs, ICDs, CRT-Ds, and accessories. Frequent product recalls pose a major challenge to the defibrillator market.
To know about the assumptions considered for the study, download the pdf brochure
However, strategic initiatives undertaken by manufacturers, such as the launch of improvement programs and the development of better-performance defibrillators, help address device-related complaints.
The Implantable Cardioverter Defibrillator segment accounted for the largest share of the global defibrillator market, by product type.
Based on product type, the market is segmented into implantable cardioverter defibrillators and external defibrillators. The implantable cardioverter defibrillator (ICDs) segment is expected to dominate this market during the forecast period. The large share of this market segment can be attributed to the increasing prevalence of cardiovascular diseases and the development of technologically advanced defibrillators
The adult patient segment, by patients type, accounted for the largest share of the global defibrillator market.
Based on patient types, the market is segmented into adult and pediatric. The adult patient segment segment accounted for the largest market share. The adult patients segment dominated the global defibrillators market with a share of 59.5%.
There were roughly 75 million adult patients (in the age group of 15 years and over) globally and 25 million pediatric patients (in the age group of 0–14 years) (Source: World Bank). According to data by the World Health Organization (WHO), around 30% of all global deaths occur due to cardiovascular disease, accounting for 17.9 million lives lost each year. About 2 in 10 deaths due to CVD (cardiovascular disease) occur in patients aged less than 65 (Source: Center for Disease Control and Prevention). The major reasons for heart disease are high blood pressure, high cholesterol, diabetes, obesity, unhealthy diets, physical inactivity, and excessive alcohol use.
The development of advanced ICDs, CRT-Ds, and AEDs, along with increasing awareness about cardiac diseases and preventive measures taken by government bodies, are the major factors contributing to the growth of the market.
On the basis of End Users, hospitals, clinics and cardiac centres segment accounted for the largest share of the global defibrillator market. While Public access markets is expected to grow with the highest growth rate during the forecast period.
Based on end users, the market is segmented into hospitals, clinics, and cardiac centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and other end users. The hospitals, clinics, and cardiac centers segment dominated the global defibrillator market, with a share of 80.2%.
A majority of all implantable cardioverter defibrillator (ICD) procedures are carried out in hospitals, clinics, and cardiac centers. Defibrillators are typically placed in critical care units (CCUs), intensive care units (ICUs), and emergency units. ICDs and external defibrillators (manual as well as AEDs) are the most common types of defibrillators used in these facilities. Although manual defibrillators are preferred and are extensively used in hospitals, the use of AEDs in hospital settings is on the rise. Early defibrillation, shorter response time, ease of use, cost-effectiveness, and a shortage of trained staff have increased the preference for AEDs in these facilities.
The growing number of cardiac implant procedures and the availability of reimbursements across developed markets are the other major factors driving the growth of this end-user segment. According to the American Heart Association, an estimated 10,000 ICD procedures are carried out each month in the US alone (data as of July 2016). Similarly, the total number of ICD implants in England increased to 72 per million population in 2014 from 66 per million population in 2012 (Source: British Heart Rhythm Society).
The development of advanced ICDs and CRT-Ds and the large number of ICD and CRT-D implant procedures performed in hospitals, clinics, and cardiac centers are the major factors contributing to the large share of this end-user segment.
The public-access markets segment includes trained and untrained personnel and bystanders who specifically use AED devices to treat sudden out-of-hospital cardiac arrests. The US and certain European and Asian countries have passed legislation regarding installing AEDs in public places and the use of AEDs by bystanders. As a result, AEDs have been installed in public places such as community centers, schools, stadiums, health clubs, recreation centers, shopping places, transportation centers, government buildings, airlines, and offices.
The public-access markets segment accounted for a share of 2.7% of the defibrillators market. This segment is expected to register the highest growth of 11.3% rate during the forecast period. The rising prevalence of sudden cardiac arrests (SCAs) is a major factor supporting the growth of this end-user segment.
The Asia Pacific region of the defibrillator market is expected to grow at the highest CAGR during the forecast period
On the basis of region, the defibrillator market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.
Growth in this market can be attributed to the rapidly growing geriatric population and the subsequent increase in the prevalence of CVDs. According to World Population Prospects 2017 (UN), the geriatric population (aged 65 and above) in the Asia Pacific region is projected to reach 1.11 billion by 2060 (~21% of the estimated total population in 2060 in this region) from 353.5 million in 2016.
The growing emphasis of key players on emerging markets in this region, new product launches, and increasing focus on supplier contracts are further fueling the growth of the defibrillators market in the Asia Pacific. However, factors such as limited accessibility of defibrillators during emergencies and a dearth of trained and skilled technicians in developing Asia Pacific countries hamper the demand for defibrillators in this region.
Prominent players in the defibrillator market include Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan), MicroPort (China), BIOTRONIK (Germany), CU Medical Systems (South Korea), METsis Medikal (Turkey), Mediana Co. Ltd. (Korea), Mindray Medical International Ltd. (China), Progetti SRL – Medical Equipment Solutions (Italy), and Schiller AG (Switzerland).
Medtronic is the leading player in the global implantable defibrillators market due to its extensive product portfolio. The company focuses on developing innovative products to treat and manage heart failure and heart rhythm disorders. In the past few years, the company has received approvals and launched several new products, including COBALT and CROME (both ICDs and CRT-Ds), which indicate the company’s strong focus on innovation. The company invests around 10% of its revenue in R&D activities to always stay ahead of the competition.
The company has a strong presence in countries across the globe, with the US accounting for 50% of its revenue. The company is not dependent on any single market and has a reasonably strong presence in the emerging markets (Middle East, Africa, and Asia) as well. The company generated roughly 30% of its revenue from the non-US developed markets in FY 2020.
The company also focuses on expanding its business to further strengthen its geographic presence in the defibrillators market. In May 2016, the company opened its Asia Pacific headquarters in Singapore to strengthen its presence in the Asia Pacific region.
Defibrillator Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$11.4 billion |
|
Estimated Value by 2026 |
$18.2 billion |
|
Growth Rate |
Poised to grow at a CAGR of 9.7% |
|
Largest Share Segments |
Implantable Cardioverter Defibrillators (ICDs) segment, Subcutaneous implantable cardioverter defibrillator , Hospitals, clinics and cardiac centres |
|
Market Report Segmentation |
Product type, Patients type, End user and Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This study categorizes the global defibrillator market into following segments & sub-segments:
By Type
- Implantable cardioverter defibrillators
- Transvenous implantable cardioverter defibrillators
- Subcutaneous implantable cardioverter defibrillators
- External defibrillators
- Manual & semi-automated external defibrillators
- Fully automated external defibrillators
- Wearable cardioverter defibrillators
By Patients type
- Adult
- Pediatrics
By End Users
- Hospitals, Clinics and Cardiac centres
- Pre-hospital care settings
- Public access markets
- Home care settings
- Alternate care facilities
- Other end users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
-
Latin America
- Brazil
- Mexico
- RoLA
- Middle East & Africa
Recent Developments:
- In July 2020, Abbott received FDA approval for its next generation ICDs and CRT-Ds under the brand name Gallant.
- In June 2020, Koninklijke Philips received FDA pre-market approval for HeartStart FR3 and HeartStart FRX AED.
- In June 2020, Asahi Kasei Corporation upgraded its Zoll AED 3 defibrillator with real CPR help and integrated child rescue and wireless connectivity features.
Frequently Asked Questions (FAQ):
What is the projected market value of the global defibrillator market?
The global market of defibrillator is projected to reach USD 18.2 billion.
What is the estimated growth rate (CAGR) of the global defibrillator market for the next five years?
The global defibrillator market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.7% from 2021 to 2026.
What are the major revenue pockets in the defibrillator market currently?
On the basis of region, the defibrillator market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA SOURCES
2.1.1.1 Indicative List of Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 3 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
2.3 MARKET DATA VALIDATION AND TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 KEY RESEARCH ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022)
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 8 DEFIBRILLATOR MARKET, BY TYPE, 2021 VS. 2026
FIGURE 9 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026
FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET
4 PREMIUM INSIGHTS (Page No. - 48)
4.1 DEFIBRILLATOR MARKET OVERVIEW
FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020
FIGURE 13 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020
4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026
FIGURE 14 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026
4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS
5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of target diseases
FIGURE 17 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030
5.2.1.2 Growing focus on providing public-access defibrillators
5.2.1.3 Training & awareness programs on defibrillators
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the use of implantable and automated external defibrillators
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
5.2.4 CHALLENGES
5.2.4.1 Frequent product recalls
TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018–2021
5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations
5.3 INDUSTRY TRENDS
5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS
5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS
5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS
5.4 PRICING ANALYSIS
TABLE 3 PRICING ANALYSIS: DEFIBRILLATOR MARKET, 2021
5.5 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 VALUE CHAIN ANALYSIS
5.6.1 RESEARCH & DEVELOPMENT
5.6.2 MANUFACTURING & ASSEMBLY
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 18 DEFIBRILLATOR MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM LANDSCAPE
5.8 REIMBURSEMENT SCENARIO
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US 2021
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT FROM NEW ENTRANTS
5.9.2 THREAT FROM SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.1 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET
5.11 PATENT ANALYSIS
5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS
FIGURE 19 PATENTS GRANTED FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS
TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
FIGURE 20 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
FIGURE 21 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION (JANUARY 2011 TO SEPTEMBER 2021)
6 DEFIBRILLATOR MARKET, BY TYPE (Page No. - 72)
6.1 INTRODUCTION
TABLE 13 DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018–2026
TABLE 15 DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018–2026
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators
6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth
TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.2.1.2 Dual-chamber ICDs
6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks—a key factor driving market growth
TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.2.1.3 Single-chamber ICDs
6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks—a key factor limiting market growth
TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market
TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.3 EXTERNAL DEFIBRILLATORS
TABLE 27 EXTERNAL DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators
TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.2.1 Increasing installation of these devices in public places to drive market growth
TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption
TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026
7 DEFIBRILLATOR MARKET, BY PATIENT TYPE (Page No. - 88)
7.1 INTRODUCTION
TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
7.2 ADULT PATIENTS
7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS
TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2018–2026
7.3 PEDIATRIC PATIENTS
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH
TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018–2026
8 DEFIBRILLATOR MARKET, BY END USER (Page No. - 92)
8.1 INTRODUCTION
TABLE 37 DEFIBRILLATORS MARKET, BY END USER TYPE, 2018–2026
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018–2026
8.3 PREHOSPITAL CARE SETTINGS
8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH
TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018–2026
8.4 PUBLIC-ACCESS MARKETS
8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS
TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018–2026
8.5 ALTERNATE CARE FACILITIES
8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH
TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018–2026
8.6 HOME CARE SETTINGS
8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS—A KEY FACTOR DRIVING MARKET GROWTH
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2026
8.7 OTHER END USERS
TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2018–2026
9 DEFIBRILLATOR MARKET, BY REGION (Page No. - 99)
9.1 INTRODUCTION
FIGURE 22 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018–2026
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: DEFIBRILLATOR MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
9.2.1 US
9.2.1.1 High adoption rate of AEDs in the country to drive market growth
TABLE 52 US: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.2.2 CANADA
9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada
TABLE 56 CANADA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.3 EUROPE
TABLE 60 EUROPE: DEFIBRILLATOR MARKET, BY COUNTRY, 2018–2026
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 64 EUROPE: EXTERNAL DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
9.3.1 GERMANY
9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany
TABLE 67 GERMANY: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.3.2 UK
9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth
TABLE 71 UK: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 74 UK: EXTERNAL DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
9.3.3 FRANCE
9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population—a key driver for market growth in France
TABLE 75 FRANCE: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.3.4 ITALY
9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy
TABLE 79 ITALY: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.3.5 SPAIN
9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain
TABLE 83 SPAIN: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.3.6 REST OF EUROPE
TABLE 87 ROE: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: DEFIBRILLATOR MARKET SNAPSHOT
TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
9.4.1 JAPAN
9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth
TABLE 98 JAPAN: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4.2 CHINA
9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth
TABLE 102 CHINA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4.3 INDIA
9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth
TABLE 106 INDIA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4.4 AUSTRALIA
9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth
TABLE 110 AUSTRALIA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4.5 SOUTH KOREA
9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea
TABLE 114 SOUTH KOREA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.4.6 REST OF ASIA PACIFIC (ROAPAC)
TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.5 LATIN AMERICA
TABLE 122 LATIN AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY, 2018–2026
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
9.5.1 BRAZIL
9.5.1.1 Large obese population in the country results in an increased demand for defibrillators
TABLE 129 BRAZIL: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.5.2 MEXICO
9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico
TABLE 133 MEXICO: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.5.3 REST OF LATIN AMERICA
TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
9.6 MIDDLE EAST & AFRICA
TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY TYPE, 2018–2026
TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026
TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER, 2018–2026
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026
10 COMPETITIVE LANDSCAPE (Page No. - 150)
10.1 INTRODUCTION
FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATOR MARKET, 2018–2021
10.2 REVENUE SHARE ANALYSIS
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 27 DEFIBRILLATOR MARKET SHARE, BY KEY PLAYER, 2020
TABLE 147 DEFIBRILLATOR MARKET: DEGREE OF COMPETITION
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
10.4.1 TERMINOLOGY/NOMENCLATURE
10.4.1.1 Stars
10.4.1.2 Emerging leaders
10.4.1.3 Pervasive players
10.4.1.4 Participants
FIGURE 28 DEFIBRILLATOR MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
FIGURE 29 DEFIBRILLATOR MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
10.6 COMPETITIVE BENCHMARKING
TABLE 148 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET
TABLE 149 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET
TABLE 150 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATOR MARKET
10.7 COMPETITIVE SCENARIO (2018–2021)
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 164)
11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MNM view)*
11.1.1 MEDTRONIC
TABLE 151 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.2 STRYKER CORPORATION
TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 153 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
11.1.4 ASAHI KASEI CORPORATION
TABLE 154 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 33 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020)
11.1.5 BOSTON SCIENTIFIC CORPORATION
TABLE 155 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 ABBOTT
TABLE 156 ABBOTT: BUSINESS OVERVIEW
FIGURE 35 ABBOTT: COMPANY SNAPSHOT (2020)
11.1.7 MICROPORT
TABLE 157 MICROPORT: BUSINESS OVERVIEW
FIGURE 36 MICROPORT: COMPANY SNAPSHOT (2020)
11.1.8 NIHON KOHDEN CORPORATION
TABLE 158 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 BIOTRONIK
TABLE 159 BIOTRONIK: BUSINESS OVERVIEW
11.1.10 CU MEDICAL SYSTEMS INC.
TABLE 160 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW
FIGURE 38 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020)
11.1.11 METSIS MEDIKAL
TABLE 161 METSIS MEDIKAL: BUSINESS OVERVIEW
11.1.12 MEDIANA CO. LTD.
TABLE 162 MEDIANA CO. LTD.: BUSINESS OVERVIEW
FIGURE 39 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020)
11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED
TABLE 163 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 40 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020)
11.1.14 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS
TABLE 164 PROGETTI SRL – MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW
11.1.15 SCHILLER AG
TABLE 165 SCHILLER AG: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 BPL MEDICAL TECHNOLOGIES
TABLE 166 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
11.2.2 METRAX GMBH (PRIMEDIC)
TABLE 167 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW
11.2.3 MS WESTFALIA GMBH
TABLE 168 MS WESTFALIA GMBH: BUSINESS OVERVIEW
11.2.4 BEXEN CARDIO
TABLE 169 BEXEN CARDIO: BUSINESS OVERVIEW
11.2.5 AXION MEDICAL EQUIPMENT LTD.
TABLE 170 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW
11.2.6 ELEMENT SCIENCE INC.
TABLE 171 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW
11.2.7 AVIVE SOLUTIONS INC.
TABLE 172 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW
11.2.8 JEEVTRONICS PVT. LTD.
TABLE 173 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW
11.2.9 HEARTHERO INC.
TABLE 174 HEARTHERO INC.: BUSINESS OVERVIEW
11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
TABLE 175 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 216)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the defibrillator market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Primary research was conducted after acquiring extensive knowledge about the global defibrillator market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as CROs, hospitals, transplant centers, healthcare service providers, commercial service providers, academia, and research organizations) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 20% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 80%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Defibrillator Market Estimation Methodology
The top-down and bottom-up approaches were used to estimate and validate the sizes of the global market and various other dependent submarkets of the defibrillator market. The research methodology used to estimate the market size includes the following details:
- The key players in the market were identified through secondary research, and their market contributions in respective regions were determined through primary and secondary research.
- This entire procedure included the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives.
- All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources.
- All the possible parameters affecting the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to reach the final quantitative and qualitative data.
- The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in the report.
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation:
After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market was validated using the bottom-up approach.
Report Objectives:
- To define, describe, and forecast the global defibrillator market on the basis of product, patients, end user, and region
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the revenue of market segments with respect to five key regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa
- To profile the key market players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as new product launches, agreements & partnerships, acquisitions, and research & development activities in the defibrillator market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global defibrillator market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe defibrillator market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
- Further breakdown of the Rest of Asia Pacific defibrillator market into New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
- Further breakdown of the Latin American defibrillaotr market into Argentina, Chile, Peru, and Colombia, among other
Growth opportunities and latent adjacency in Defibrillator Market